Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CDLX
CDLX logo

CDLX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Cardlytics Inc (CDLX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.970
1 Day change
-2.02%
52 Week Range
3.280
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Cardlytics Inc (CDLX) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is currently in a bearish trend with weak financial performance, negative analyst sentiment, and no strong positive catalysts to support a long-term investment decision.

Technical Analysis

The stock is in a bearish trend with MACD below 0 and negatively expanding, RSI at 45.719 in the neutral zone, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support is at 0.903, and resistance is at 1.032. The stock closed at 0.9698, slightly above the pivot of 0.967.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
4

Positive Catalysts

  • Hedge funds are increasing their positions, with a 361.26% increase in buying over the last quarter.

Neutral/Negative Catalysts

  • Insiders are selling, with a 171.74% increase in selling activity over the last month. Analysts have lowered price targets, citing the impact of the BofA exit and Bridg divestiture. Financial performance is weak, with significant YoY declines in revenue, net income, EPS, and gross margin.

Financial Performance

In Q4 2025, revenue dropped by -24.19% YoY to $56.1M, net income dropped by -47.08% YoY to -$8.25M, EPS dropped by -51.61% YoY to -0.15, and gross margin dropped by -3.28% YoY to 45.45.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have a neutral to bearish outlook on CDLX. Evercore ISI lowered the price target to $1 and maintained an In Line rating. Lake Street reduced the price target to $1.25 and maintained a Hold rating, citing near-term challenges and a 'show me' sentiment.

Wall Street analysts forecast CDLX stock price to rise
4 Analyst Rating
Wall Street analysts forecast CDLX stock price to rise
0 Buy
3 Hold
1 Sell
Hold
Current: 0.990
sliders
Low
1.5
Averages
1.63
High
2
Current: 0.990
sliders
Low
1.5
Averages
1.63
High
2
Evercore ISI
In Line
downgrade
$2 -> $1
AI Analysis
2026-03-06
Reason
Evercore ISI
Price Target
$2 -> $1
AI Analysis
2026-03-06
downgrade
In Line
Reason
Evercore ISI lowered the firm's price target on Cardlytics to $1 from $2 and keeps an In Line rating on the shares following the company's Q4 report and Q1 guidance.
Lake Street
Hold
downgrade
2026-03-05
Reason
Lake Street
Price Target
2026-03-05
downgrade
Hold
Reason
Lake Street lowered the firm's price target on Cardlytics to $1.25 from $1.50 and keeps a Hold rating on the shares. With Q1 guidance resetting numbers across the board, the firm believes "the bar is appropriately level set" to reflect the near-term impact of the BofA exit and Bridg divestiture, though it adds that shares remain in "show me" territory.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CDLX
Unlock Now

People Also Watch